Cytek Biosciences Inc (NASDAQ:CTKB)

15.86
Delayed Data
As of Oct 04
 +0.56 / +3.66%
Today’s Change
7.38
Today|||52-Week Range
26.50
-2.82%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Cytek Biosciences Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 15.00. The median estimate represents a +0.88% increase from the last price of 15.86.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Cytek Biosciences Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.01
Sales
$43.3M
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -58.33%
 
 
 
 
 
 
Growthannually -50.00%
 
 
 

Sales

Growthquarterly 7.74%
 
 
 
 
 
 
Growthannually 30.32%
 
 
 
Key to the earnings and sales forecast charts.